Fei Lu

This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Anacor Pharmaceuticals, Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd.. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fei Lu. Retrieved from https://idiyas.com/inventor/fei-lu-pvbwew4r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 6)

% Patents Active = 80.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Suzhou, CN (2017 - 2020)
Jiangsu, CN (2022 - 2023)

Company Filing History:

2 out of 70

Anacor Pharmaceuticals, Inc.

patents

1 out of 20

Crystal Pharmaceutical (Suzhou) Co., Ltd.

patents

1 out of 22

Crystal Pharmatech Co., Ltd.

patents

4. 1 out of 2

Crystal Pharmatech Inc.

patents

5. 1 out of 11

Suzhou Pengxu Pharmatech Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2017-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11773113 - Crystal forms of crisaborole in free form and preparation method and use thereof (2023-10-03),

2. 11447506 - Crystal forms of crisaborole in free form and preparation method and use thereof (2022-09-20),

3. 10604528 - Galunisertib crystalline form, preparation method thereof and use thereof (2020-03-31),

4. 10266523 - Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4'-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof (2019-04-23),

5. 9751889 - Crystalline form I of ibrutinib (2017-09-05),

Title: Fei Lu: A Profile of an Emerging Innovator in Pharmaceuticals

Introduction: Fei Lu is an accomplished professional based in China, known for his work with notable companies in the pharmaceutical industry. Despite holding no patents to his name, his experience and collaborations have contributed significantly to advancements in healthcare.

Latest Patents: Currently, Fei Lu does not hold any patents. This status highlights the potential for future innovations he may bring to the industry.

Career Highlights: Throughout his career, Fei Lu has been associated with reputable organizations such as Anacor Pharmaceuticals, Inc. and Suzhou Pengxu Pharmatech Co., Ltd. His roles in these companies have allowed him to hone his skills and expertise in pharmaceutical development and innovation.

Collaborations: During his time in the industry, Fei Lu has worked alongside Yanfeng Zhang, an experienced professional in the field. Their collaboration suggests a strong synergy that may lead to future innovations and contributions to the pharmaceutical sector.

Conclusion: While Fei Lu currently has no patents to his name, his experience in prominent pharmaceutical companies and collaborations with skilled professionals indicate a promising future in innovation. His journey in the industry reflects the potential for groundbreaking contributions and the ongoing evolution of healthcare solutions.

Profile summary based on public USPTO records.